4//SEC Filing
Galante Joseph C 4
Accession 0001628280-25-013541
CIK 0001087294other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:13 PM ET
Size
4.7 KB
Accession
0001628280-25-013541
Insider Transaction Report
Form 4
Galante Joseph C
Director
Transactions
- Award
Common Stock
2025-03-17$5.17/sh+1,000$5,170→ 61,856 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 17, 2026.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001632384
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:13 PM ET
- Size
- 4.7 KB